|
Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
RECRUITINGN/ASponsored by Hebrew SeniorLife
Actively Recruiting
PhaseN/A
SponsorHebrew SeniorLife
Started2023-11-13
Est. completion2026-06-30
Eligibility
Age60 Years – 106 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05950607
Summary
The goal of this pragmatic cluster randomized clinical trial is to compare management of suspected infection in nursing home residents with dementia The main questions it aims to answer whether residents with dementia in nursing homes randomized to use a multicomponent intervention to optimize suspected infection management ( versus usual care) use less antibiotics and fewer burdensome interventions.
Eligibility
Age: 60 Years – 106 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Age \> 60 2. A diagnosis of dementia (any type) 3. Cognitive Functional Scale (CFS) \> 1 4. NH length of stay \>90 days The CFS score categorizes cognitive impairment status based on data in the electronic health record into: 1. None, 2. Mild, 3. Moderate, and 4. Severe (advanced). For the primary outcome, the analysis will be restricted to residents with a CFS score of 3 or 4. Exclusion Criteria: 1. Less than 60 years of age 2. Living in nursing home for less than 90 days 3. Does not have diagnosis of dementia 4. Does not meet CFS \>1 score
Conditions4
Alzheimer DiseaseAlzheimer's DiseaseDementiaInfections
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorHebrew SeniorLife
Started2023-11-13
Est. completion2026-06-30
Eligibility
Age60 Years – 106 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05950607